Vyxeos for Re-induction Treatment of Acute Myeloid Leukemia Patients With Persistent Disease After Induction

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Vyxeos for Re-induction Treatment of Acute Myeloid Leukemia Patients With Persistent Disease After Induction	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm	Recruiting	Phase 1 / Phase 2	2026-09-09		NCT04049539

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Ohio State University Comprehensive Cancer Center	112

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Ohio State University Comprehensive Cancer Center	Columbus	United States	548
UC Davis Comprehensive Cancer Center	Sacramento	United States	23

Clinical trials